Cara Therapeutics (NASDAQ:CARA) had a positive start to its Wednesday as the stock received good news regarding the latest clinical trial results of one of its medications. The Stamford, Conn.-based ...

What: Shares in Cara Therapeutics are surging higher by 30% today after the company reported that its lead product candidate CR845 met its primary endpoint in a mid stage trial. So what: Cara ...

Shares of Cara Therapeutics (NASDAQ: CARA) were soaring 16.8% higher as of 10:49 a.m. EDT on Wednesday. The big jump came after the biotech announced results from a phase 3 clinical study evaluating ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Cara Therapeutics Inc. (NASDAQ: CARA) shares made a solid ...